Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation
Crossref DOI link: https://doi.org/10.1007/s12253-017-0255-x
Published Online: 2017-06-02
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
da Silva, Glenda Nicioli
Filoni, Leandro Toshio
Salvadori, Maria Cecília
Salvadori, Daisy Maria Fávero
License valid from 2017-06-02